• Users Online: 78
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
ORIGINAL ARTICLE
Year : 2015  |  Volume : 1  |  Issue : 1  |  Page : 21-26

Association of plasma fibrinogen and serum high-sensitivity C-reactive protein in type 2 diabetes mellitus


1 Department of Biochemistry, Pondicherry Institute of Medical Sciences, Puducherry; Department of Biochemistry, Maharaja Krushna Chandra Gajapati Medical College and Hospital, Berhampur, India
2 Department of Biochemistry, Maharaja Krushna Chandra Gajapati Medical College and Hospital, Berhampur; Department of Biochemistry, Shriram Chandra Bhanja Medical College and Hospital, Cuttack, Odisha, India
3 Department of Pathology, Pondicherry Institute of Medical Sciences, Puducherry, India

Correspondence Address:
RajLaxmi Sarangi
Department of Biochemistry, Pondicherry Institute of Medical Sciences, Puducherry - 605 014
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


Rights and PermissionsRights and Permissions

Introduction: Impaired fibrinolysis and low-grade systemic inflammation are postulated to be associated with the pathogenesis of type 2 diabetes mellitus (T2DM) with its micro and macrovascular complications. However, this mechanism is complex and poorly understood. Materials and Methods: Fasting plasma glucose (FPG), plasma fibrinogen, serum high-sensitivity C-reactive protein (hs-CRP), and lipid parameters were measured among eighty, nonobese, adult type 2 diabetic males (age: 40–65 years) (without complications [n = 40, Group 2], with retinopathy [n = 16, Group 3], with hypertension [n = 24, Group 4]), and compared with age- and gender-matched healthy controls (n = 40, Group 1). Results: The mean age of subjects in Groups 1, 2, 3, and 4 were 51 ± 7.2, 49 ± 5.3, 51.5 ± 7.2, and 49.3 ± 5.3 years, respectively (P = 0.33). Fibrinogen, FPG, and hs-CRP were significantly higher among diabetics than controls (P < 0.001). Fibrinogen was found to be significantly higher (P = 0.01) among diabetics with complications than without complications, though the results were similar between retinopathy group (Group 3) and hypertension group (Group 4) (462.3 ± 63.9 vs. 459.1 ± 53.3 mg/dl, respectively, P > 0.05). Significant positive correlation was noted between fibrinogen and hs-CRP among Group 2 (r = 0.37, P = 0.02), Group 3 (r = 0.67, P = 0.005), and Group 4 (r = 0.74, P = 0.000). On linear regression analysis, the association between fibrinogen and hs-CRP was found to be significant among all diabetic subgroups. Association of fibrinogen with lipid parameters was inconsistent in all subgroups. Conclusion: Fibrinogen may be considered as an inflammatory biomarker in T2DM, and fibrinogen-lowering agents may be useful in lowering the morbidity and mortality.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed2484    
    Printed122    
    Emailed0    
    PDF Downloaded283    
    Comments [Add]    

Recommend this journal